Results 10,461-10,480 of 12,424 for speaker:Louise O'Reilly

Joint Oireachtas Committee on the Eighth Amendment of the Constitution: International Legal and Services Context: Dr. Gilda Sedgh, Guttmacher Institute and Ms Leah Hoctor, Center for Reproductive Rights (8 Nov 2017)

Louise O'Reilly: I will not need the full six minutes as my question is a very simple one. It concerns the word "risk". We know from the Citizens' Assembly what it is that we are asked to consider here. The assembly has a gradation of risk or "serious risk" to use its own term. There are various definitions of what does or does not constitute risk. In Dr. Sedgh's experience, is it possible or even...

Joint Oireachtas Committee on the Eighth Amendment of the Constitution: International Legal and Services Context: Dr. Gilda Sedgh, Guttmacher Institute and Ms Leah Hoctor, Center for Reproductive Rights (8 Nov 2017)

Louise O'Reilly: Yes. My apologies. I should have been clearer.

Joint Oireachtas Committee on the Eighth Amendment of the Constitution: Risks to Mental Health: Dr. Anthony McCarthy, National Maternity Hospital, Holles Street (8 Nov 2017)

Louise O'Reilly: That is fine. To return to one of the points made by Senator Ruane, I do think there has to be a certain amount of respect given to those of us on the committee when we are discussing pregnancy related issues who have had that very personal experience. I found the content of some of what was said quite disrespectful. I do not intend to get into a row with anybody about it. In fact, the...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I thank the witnesses for their evidence. I have a number of questions and I would imagine that none will shock or surprise the witnesses. Following our engagement with Alpha One Foundation, specifically in respect of Respreeza, I have stated publicly that the families of the patients involved have been treated disgracefully. I would apportion blame equally to all involved in this. The...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: To follow on from a point made by Deputy Kelleher, the rare diseases plan runs from 2014 to 2018 so we are very far into it. It strikes me that very little has been done. Will the witnesses give an indication as to whether they feel all of this work will be completed by the end of the plan? That is what people want to know. The witnesses might give us an idea of what will not be achieved...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: All members have done some research on the issue. Is it correct that there are young children on the drug in the countries the witness listed where conditional access has been granted?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: Let us take Britain as an example. In England and Northern Ireland the drug is being reimbursed. Is that being done on a conditional basis or otherwise?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: The families of the kids who are waiting to hear about the availability of this drug are very anxious and are watching these proceedings. They do not believe a mistake was made but, rather, a certain amount of compassion was shown. With regard to most of the countries where it is available or the countries the witness listed where it is not available in any form, conditional or otherwise,...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I suspect Professor Barry is playing with words because I think it is available to people via the public system but we can agree to differ on that.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: As regards the Irish system, the witness knows the families are very anxious to know what will happen. There is a court case in progress and perhaps the witness will address that at a later stage.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I have something that specifically relates-----

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I understand that. This relates to a question I asked.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I wish to ask for clarification on that issue. Is anyone at the moment on a programme that for whatever reason has not received full endorsement where the HSE is administering the drug? The difficulty that arises for those people is who is going to administer the drug. Is anyone at the moment having the drug administered by the HSE even though it is not necessarily being fully refunded?...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: No, I am asking about patients who are separate to that and whether there is a scenario in the HSE whereby people are on a drug but the HSE is not administering it so there is no protocol that exists other than the one for the management of people at the end of clinical trials.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: The HSE would have no involvement in the administration of it? Is Mr. Flanagan certain of that?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I agree with the sentiments expressed. People have made huge amounts of money from this situation. I fully respect the role that the HSE plays in trying to get the best value for money. We have witnessed scenes where people protested at the gates of Leinster House. People have put pressure on us to put pressure on the HSE. The issue is cyclical, which is really unhelpful. I echo what...

Written Answers — Department of Health: Hospital Procedures (8 Nov 2017)

Louise O'Reilly: 155. To ask the Minister for Health when transvaginal mesh (details supplied) was first used by the HSE; and if he will make a statement on the matter. [47236/17]

Written Answers — Department of Health: Emergency Departments (8 Nov 2017)

Louise O'Reilly: 158. To ask the Minister for Health the status of a request by Letterkenny University Hospital to reopen its short-stay ward and 20 beds to alleviate the pressure on the accident and emergency department at the hospital; if the hospital's related request for additional staff to operate the ward will be addressed; and if he will make a statement on the matter. [47249/17]

Order of Business (7 Nov 2017)

Louise O'Reilly: I am sorry, but I asked a specific question about whether the Minister would meet the families.

Order of Business (7 Nov 2017)

Louise O'Reilly: It is not a supplementary. It was part of my original question.